Free Trial

Dimensional Fund Advisors LP Grows Holdings in Corteva, Inc. (NYSE:CTVA)

Corteva logo with Consumer Staples background

Dimensional Fund Advisors LP raised its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,794,086 shares of the company's stock after acquiring an additional 102,109 shares during the quarter. Dimensional Fund Advisors LP owned 0.70% of Corteva worth $273,062,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CTVA. World Investment Advisors LLC acquired a new stake in Corteva in the third quarter valued at $319,000. Wilmington Savings Fund Society FSB raised its stake in shares of Corteva by 247.9% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 44,080 shares of the company's stock worth $2,591,000 after buying an additional 31,411 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Corteva by 6.1% during the 3rd quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock worth $860,746,000 after buying an additional 856,007 shares during the last quarter. 1ST Source Bank raised its stake in shares of Corteva by 1.9% during the 3rd quarter. 1ST Source Bank now owns 19,195 shares of the company's stock worth $1,128,000 after buying an additional 367 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Corteva by 6.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock worth $270,764,000 after buying an additional 288,885 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company's stock, valued at $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.14% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CTVA shares. Oppenheimer lifted their price target on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. Royal Bank of Canada lifted their price target on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. UBS Group cut their price target on Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a research note on Friday, January 10th. BNP Paribas upgraded Corteva to a "hold" rating in a research report on Monday, February 10th. Finally, The Goldman Sachs Group assumed coverage on Corteva in a research report on Thursday, March 13th. They set a "buy" rating and a $71.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $68.13.

Read Our Latest Stock Report on CTVA

Corteva Trading Down 0.3 %

Shares of NYSE:CTVA traded down $0.21 during trading on Friday, reaching $61.50. 1,803,138 shares of the stock were exchanged, compared to its average volume of 3,325,474. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The firm has a market cap of $42.01 billion, a price-to-earnings ratio of 47.67, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The firm's 50-day moving average price is $60.71 and its 200 day moving average price is $60.44.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's payout ratio is currently 52.71%.

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Further Reading

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines